对艾滋病(AIDS)敏感的多种抗感染药物已用于临床,虽然某些药物能暂时控制感染,但由于患者持续存在着潜伏性免疫缺陷,故常常复发或不可避免地代之以其它微生物感染。对于本病唯一有希望的治疗是控制、消灭引起艾滋病的“亲人 T 细胞Ⅲ型病毒”(Human T—Lymphotropic virus type Ⅲ,HTLV—Ⅲ)和“淋巴腺病相关病毒”(Lymphadenopathy—associated Virus,LAV),或纠正患者潜在的免疫缺陷。因目 A number of anti-infectives that are sensitive to AIDS have been used in clinical practice. Although some drugs temporarily control the infection, patients often relapse or inevitably become infected with other microorganisms due to persistent latent immunodeficiency. The only promising treatment for this disease is the control and elimination of the AIDS-causing human T-Lymphotropic virus type III (HTLV-III) and Lymphadenopathy-associated Virus LAV), or correct the patient’s underlying immune deficiency. Due to the purpose